Navigation Links
Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

the treatment of EGFR-expressing, metastatic colorectal carcinoma (mCRC) in combination with irinotecan for patients who are refractory to irinotecan-based chemotherapy, and as a single agent for patients who are intolerant to irinotecan-based therapy. The effectiveness of ERBITUX for the treatment of EGFR-expressing mCRC is based on objective response rates. Currently, no data are available that demonstrate an improvement in disease-related symptoms or increased survival with ERBITUX for the treatment of EGFR-expressing mCRC.

For full prescribing information, including boxed WARNINGS regarding infusion reactions and cardiopulmonary arrest, visit http://www.ERBITUX.com.

Important Safety Information

Grade 3/4 infusion reactions, rarely with fatal outcome (<1 in 1000), occurred in approximately 3% (46/1485) of patients receiving ERBITUX (Cetuximab) therapy. These reactions are characterized by rapid onset of airway obstruction (bronchospasm, stridor, hoarseness), urticaria, hypotension, and/or cardiac arrest. Severe infusion reactions require immediate and permanent discontinuation of ERBITUX therapy.

Most reactions (90%) were associated with the first infusion of ERBITUX despite the use of prophylactic antihistamines. Caution must be exercised with every ERBITUX infusion as there were patients who experienced their first severe infusion reaction during later infusions. A 1-hour observation period is recommended following the ERBITUX infusion. Longer observation periods may be required in patients who experience infusion reactions.

Cardiopulmonary arrest and/or sudden death occurred in 2% (4/208) of patients with squamous cell carcinoma of the head and neck treated with radiation therapy and ERBITUX as compared to none of 212 patients treated with radiation therapy alone. Fatal events occurred within 1 to 43 days after the last ERBITUX treatment. ERBITUX in combination with radia
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:12/15/2009)... Volcano Corporation (Nasdaq: VOLC ), ... tools - including Fractional Flow Reserve (FFR), Intravascular ... Tomography (OCT) - designed to enhance the diagnosis ... announced today the placement of over 2,500 s5 ... consoles was first launched in April 2006, with ...
(Date:12/15/2009)... CITY, Dec. 15 Sonic Innovations, Inc. ... services and solutions, donated $10,000 to its local ... Dec. 14, 2009. ,, Sonic Innovations President Paul ... Feeding America member, the Utah Food Bank, at ... employees also participated in an office food drive ...
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC Bulletin Board: ... advanced preclinical platforms and tumor specific data to ... its financial results for the second fiscal quarter ... Company,s financial results are available in the Company,s ... revenues for the second quarter of 2010 were ...
Breaking Medicine Technology:Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Sonic Innovations, Inc. Donates $10,000 to Feeding America 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference 14650 1NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference 14650 2Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9 000 Patients Annually 5846 1Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9 000 Patients Annually 5846 2Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9 000 Patients Annually 5846 3Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 1Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 2
... May 19 Ikaria Holdings, Inc., a fully,integrated ... completed dosing of its Phase 1a trial for ... The study was a Phase 1, randomized, single ... single bolus injection of IK-1001,in healthy volunteers to ...
... MARSEILLE, France, May 19 IPSOGEN SA (Marseille and ... diagnostic,assays for blood & breast cancers, announced today that ... (MDACC, Houston, TX) will,present the results of two studies ... Meeting, held in Chicago from May 30 to June ...
Other Medicine Technology:Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 2Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 2Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 4
(Date:12/15/2009)... have successfully developed a new electrophoretic method for ... blood. The technique, using SARCOSYL-PAGE, has specifically ... the performance characteristics of SDS-PAGE for detecting other ... a grant from the World Anti-Doping Agency (WADA), ... Testing and Analysis published by Wiley-Blackwell. , ...
(Date:12/15/2009)... The Food and Health Bureau has invited ... parties in developing private hospitals at four sites in ... submitting EOI is March 31, 2010. ,, At ... Dr. York Chow, said the promotion of private hospital ... and a major Hong Kong government policy announced by ...
(Date:12/15/2009)... 15 Vitech Systems Group, a leading ... (CRM) software, announced today that it has completed ... the Screen Actors Guild-Producers Pension & Health Plans ... service capabilities to SAG-PH call center personnel in ... installed using Vitech,s V3 Benefits Administration System which ...
(Date:12/15/2009)... have released some sobering statistics concerning the parallel rise in diabetes ... an effective means of combating this trend afflicting their workforce. ... ... of diabetes are climbing across America due in large part to ... American Diabetes Association has stated that the rate of diabetes could ...
(Date:12/15/2009)... Dec. 15 Team In Training (TNT), ... charity sports training program, has reached a ... blood cancer research and patient services. ,, For ... pre-eminent charity endurance sports training program, preparing amateurs ... marathon, triathlon, 100-mile century cycle ride or hike ...
Breaking Medicine News(10 mins):Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3
... is the premier sponsor of the 3rd Annual ... two-day event, held in Boston, MA on July,22-23, ... to the,next level., Accenx is the leading ... as a Service (SaaS) solution to national and,regional ...
... and administration in Penn State,s College of Health and ... grant from the Robert Wood Johnson Foundation (RWJF) to ... Forces for Quality (AF4Q).", This grant is in addition ... Johnson Foundation in 2007 and expands the scope of ...
... Calif., July 1 Senetek PLC (OTC,Bulletin Board: ... development,of technologies that target the science of healthy ... its marketing agreement with Triax,Aesthetics LLC for Pyratine-6(TM), ... controlled and managed directly by the Company., ...
... Hackbarth (MedPAC) and Bruce Bradley (General,Motors) - to ... The ABIM Foundation,will dedicate its efforts over ... medical professionalism and accountability in health care toward ... addition, the Foundation announced that officers of its ...
... Opus Healthcare Solutions, Inc.,a leading national provider ... CPA, as controller. Based at the company,s ... all accounting and financial,administrative functions., (Photo: ... ), Bechtold joined Opus Healthcare Solutions ...
... over 55 use colonoscopies for early detection of cancer, ... the costs since 2002. This was shown by an ... current edition of Deutsches rzteblatt International (Dtsch ... , The authors evaluated 245 263 colonoscopies performed ...
Other Medicine News:Health News:Accenx Technologies, a Premier Sponsor as the Educational Underwriters of the 3rd Annual World Congress Leadership Summit on The Road to Interoperability 2Health News:Researcher receives $4 million from RWJ Foundation to study health quality reform project 2Health News:Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM) 2Health News:ABIM Foundation Announces New Focus and Governance 2Health News:ABIM Foundation Announces New Focus and Governance 3Health News:Opus Healthcare Solutions Names Ray Bechtold as Controller 2
... void filler is an extrudable, moldable bone void ... for use anywhere in the skeletal system, including ... resorbable, serving as a temporary scaffolding for new ... visible on X-ray, making healing easier to assess. ...
... a synthetic porous ceramic graft material composed of ... phase that comprises 70% of human bone. TCP ... that allows the attachment of bone forming cells ... within granules as well as between each granule. ...
Schuknecht-Weitlaner retractor, sharp, angled arms....
Weitlaner Beckmann retractor, sharp prongs, SS....
Medicine Products: